Skip to main content

Table 1 Host characteristics

From: Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients

 ccRCC cases, n (%)
VariablesEarly stageaLate stagea
Age, mean (SD)58.46 (9.85)59.57 (8.45)
BMI, mean (SD)30.70 (6.39)30.12 (7.07)
Sex
 Male67 (74.44)68 (73.91)
 Female23 (25.56)24 (26.09)
Age
 < =6044 (48.89)43 (46.74)
 > 6046 (51.11)49 (53.26)
Smoking status
 Never40 (44.44)43 (46.74)
 Former43 (47.78)42 (45.65)
 Current7 (7.78)7 (7.61)
BMI
 < 3045 (50.00)57 (61.96)
>= 3045 (50.00)35 (38.04)
Hypertension
 Yes65 (72.22)68 (73.91)
 No25 (27.78)24 (26.09)
Diabetes
 Yes19 (21.11)17 (18.48)
 No71 (78.89)75 (81.52)
Tumor gradeb
 110 (0.00)
 243 (47.78)9 (9.78)
 337 (41.11)52 (56.52)
 48 (8.89)29 (31.52)
 None1 (1.11)2 (2.17)
Recurrence
 Yes17 (18.9)74 (80.4)
 No73 (81.1)18 (19.6)
Death
 Yes11 (33.3)22 (66.7)
 No79 (53.0)70 (47.0)
Treatment
 Surgery-only64 (70.33)76 (83.52)
 Surgery-plus-chemotherapy27 (29.67)15 (16.48)
  1. aEarly stage indicated stage I or II disease; late stage indicated stage III disease. The staging criteria derived from NCCN guidelines 2019 v.2.0
  2. bTumor grade based on Fuhrman criteria